Go to deals
Healthcare | Private Equity

Avicenna Holdings Limited has been acquired by Juno Health

The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.

Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.

Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.

Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”

Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.

Parties

Talk to the deal team

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Rebecca McCredie

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Bolster Investment Partners has acquired a majority stake in Eternal Sun
Private Equity | Energy

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Learn more
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
Private Equity | Construction & Engineering Services | Energy | TMT

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.

Learn more